We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Assurant
AIZ
$14B
| $10.1M | 0.08% |
94,645
+71,834
| +315% | +$7.1M |
|
|
DEACU
277
DELISTED
Diamond Eagle Acquisition Corp. Unit
DEACU
| $10.1M | 0.08% |
+1,000,000
| New | +$10.1M |
|
278
NOV
NOV
$7.11B
| $10M | 0.08% |
+450,623
| New | +$10.9M |
|
|
ABMD
279
DELISTED
Abiomed Inc
ABMD
| $9.94M | 0.08% |
38,164
+33,615
| +739% | +$8.92M |
|
280
Charles River Laboratories
CRL
$11.6B
| $9.9M | 0.08% |
69,783
+62,299
| +832% | +$8.45M |
|
|
HOME
281
DELISTED
At Home Group Inc.
HOME
| $9.89M | 0.08% |
1,484,406
+691,186
| +87% | +$12.2M |
|
282
Walmart Inc
WMT
$900B
| $9.86M | 0.08% |
267,756
+255,816
| +2,143% | +$8.82M |
|
|
SEE
283
DELISTED
Sealed Air
SEE
| $9.82M | 0.08% |
229,666
-471,527
| -67% | -$20.8M |
|
284
EnerSys
ENS
$6.69B
| $9.76M | 0.08% |
142,430
+142,106
| +43,860% | +$9.29M |
|
285
Simply Good Foods
SMPL
$941M
| $9.73M | 0.08% |
403,953
+363,742
| +905% | +$8.25M |
|
286
Suncor Energy
SU
$75.4B
| $9.69M | 0.08% |
310,320
+287,020
| +1,232% | +$9.18M |
|
|
SRCI
287
DELISTED
SRC Energy Inc
SRCI
| $9.68M | 0.08% |
1,951,801
-787,555
| -29% | -$4.29M |
|
288
Regal Rexnord
RRX
$13.5B
| $9.64M | 0.08% |
+117,942
| New | +$9.5M |
|
|
VIAB
289
DELISTED
Viacom Inc. Class B
VIAB
| $9.59M | 0.08% |
321,184
+40,859
| +15% | +$1.19M |
|
290
HealthEquity
HQY
$8.46B
| $9.59M | 0.08% |
146,653
+137,490
| +1,500% | +$9.57M |
|
291
WesBanco
WSBC
$4.03B
| $9.59M | 0.08% |
248,706
+238,350
| +2,302% | +$9.18M |
|
292
Medifast
MED
$108M
| $9.56M | 0.08% |
74,500
+46,740
| +168% | +$6.49M |
|
293
PUT
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
| $9.45M | 0.08% |
+66,300
| New | +$8.42M |
|
294
Repligen
RGEN
$8.2B
| $9.45M | 0.08% |
+109,886
| New | +$7.49M |
|
295
Mondelez International
MDLZ
$80.2B
| $9.44M | 0.08% |
+175,222
| New | +$9.1M |
|
296
CGI
GIB
$15B
| $9.44M | 0.08% |
122,503
+120,903
| +7,556% | +$8.79M |
|
297
Norfolk Southern
NSC
$76.1B
| $9.43M | 0.08% |
47,307
-49,972
| -51% | -$9.91M |
|
|
AVYA
298
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $9.43M | 0.08% |
791,792
-48,420
| -6% | -$741K |
|
299
TechTarget
TTGT
$323M
| $9.41M | 0.08% |
442,651
-112,131
| -20% | -$2.1M |
|
300
Teledyne Technologies
TDY
$30.1B
| $9.33M | 0.08% |
+34,075
| New | +$8.49M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.